Myelosuppression Rates with Administration of Nafcillin with and without Rifampin in Pediatric Patients

Myelosuppression, a potential adverse reaction of nafcillin and rifampin, is rarely documented in pediatric populations. The objective of this study is to describe the incidence of myelosuppression in pediatric patients receiving nafcillin or a combination of nafcillin and rifampin therapy. This ret...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuriakose, Jolly, Kaplansky, Michelle, Sierra, Caroline M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9230949/
https://www.ncbi.nlm.nih.gov/pubmed/35736658
http://dx.doi.org/10.3390/pediatric14020036

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9230949/
https://www.ncbi.nlm.nih.gov/pubmed/35736658
http://dx.doi.org/10.3390/pediatric14020036

Ejemplares similares